Ալենդրոնաթթու

main_info

  • trade_name:
  • Ալենդրոնաթթու շաբաթում 1դեղահատ 70մգ
  • dosage:
  • 70մգ(4/1x4/), բլիստերում
  • pharmaceutical_form:
  • դեղահատեր
  • prescription_type:
  • Դեղատոմսով
  • medicine_domain:
  • Human
  • medicine_type:
  • Allopathic

documents

localization

  • country:
  • Ալենդրոնաթթու շաբաթում 1դեղահատ 70մգ
    አርሜኒያ
  • language:
  • አማርኛ

other_info

status

  • source:
  • Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում - Armenia
  • last_update:
  • 31-05-2018

17-4-2019


Committee for Advanced Therapies (CAT): 23-25 January 2019, European Medicines Agency, London, UK, from 23/01/2019 to 25/01/2019

Committee for Advanced Therapies (CAT): 23-25 January 2019, European Medicines Agency, London, UK, from 23/01/2019 to 25/01/2019

Committee for Advanced Therapies (CAT): 23-25 January 2019, European Medicines Agency, London, UK, from 23/01/2019 to 25/01/2019

Europe - EMA - European Medicines Agency

25-3-2019


Pharmacovigilance Risk Assessment Committee (PRAC): 14-17 January 2019, European Medicines Agency, London, UK, from 14/01/2019 to 17/01/2019

Pharmacovigilance Risk Assessment Committee (PRAC): 14-17 January 2019, European Medicines Agency, London, UK, from 14/01/2019 to 17/01/2019

Pharmacovigilance Risk Assessment Committee (PRAC): 14-17 January 2019, European Medicines Agency, London, UK, from 14/01/2019 to 17/01/2019

Europe - EMA - European Medicines Agency

25-3-2019


Paediatric Committee (PDCO): 13-16 November 2018, European Medicines Agency, London, UK, from 13/11/2018 to 16/11/2018

Paediatric Committee (PDCO): 13-16 November 2018, European Medicines Agency, London, UK, from 13/11/2018 to 16/11/2018

Paediatric Committee (PDCO): 13-16 November 2018, European Medicines Agency, London, UK, from 13/11/2018 to 16/11/2018

Europe - EMA - European Medicines Agency

21-2-2019


Info day for micro, small and medium-sized enterprises (SMEs): regulatory toolbox for medicines and combined devices developers, European Medicines Agency, London, UK, from 26/10/2018 to 26/10/2018

Info day for micro, small and medium-sized enterprises (SMEs): regulatory toolbox for medicines and combined devices developers, European Medicines Agency, London, UK, from 26/10/2018 to 26/10/2018

Info day for micro, small and medium-sized enterprises (SMEs): regulatory toolbox for medicines and combined devices developers, European Medicines Agency, London, UK, from 26/10/2018 to 26/10/2018

Europe - EMA - European Medicines Agency

11-2-2019


Online training: How to submit an 'Initial Notification' for parallel distribution via IRIS, European Medicines Agency, London, UK, from 31/01/2019 to 31/01/2019

Online training: How to submit an 'Initial Notification' for parallel distribution via IRIS, European Medicines Agency, London, UK, from 31/01/2019 to 31/01/2019

Online training: How to submit an 'Initial Notification' for parallel distribution via IRIS, European Medicines Agency, London, UK, from 31/01/2019 to 31/01/2019

Europe - EMA - European Medicines Agency

11-2-2019


Online training: How to register for access to IRIS, European Medicines Agency, London, UK, from 31/01/2019 to 31/01/2019

Online training: How to register for access to IRIS, European Medicines Agency, London, UK, from 31/01/2019 to 31/01/2019

Online training: How to register for access to IRIS, European Medicines Agency, London, UK, from 31/01/2019 to 31/01/2019

Europe - EMA - European Medicines Agency

8-2-2019


Multi-stakeholder workshop with the HMA/EMA task force on availability of authorised medicines, European Medicines Agency, London, UK, from 09/11/2018 to 09/11/2018

Multi-stakeholder workshop with the HMA/EMA task force on availability of authorised medicines, European Medicines Agency, London, UK, from 09/11/2018 to 09/11/2018

Multi-stakeholder workshop with the HMA/EMA task force on availability of authorised medicines, European Medicines Agency, London, UK, from 09/11/2018 to 09/11/2018

Europe - EMA - European Medicines Agency

1-2-2019


Committee for Herbal Medicinal Products (HMPC): 14-16 January 2019, European Medicines Agency, London, UK, from 14/01/2019 to 16/01/2019

Committee for Herbal Medicinal Products (HMPC): 14-16 January 2019, European Medicines Agency, London, UK, from 14/01/2019 to 16/01/2019

Committee for Herbal Medicinal Products (HMPC): 14-16 January 2019, European Medicines Agency, London, UK, from 14/01/2019 to 16/01/2019

Europe - EMA - European Medicines Agency

25-1-2019


Industry stakeholder meeting on Brexit and operation of the centralised procedure for human and veterinary medicine products, European Medicines Agency, London, UK, from 28/01/2019 to 28/01/2019

Industry stakeholder meeting on Brexit and operation of the centralised procedure for human and veterinary medicine products, European Medicines Agency, London, UK, from 28/01/2019 to 28/01/2019

Industry stakeholder meeting on Brexit and operation of the centralised procedure for human and veterinary medicine products, European Medicines Agency, London, UK, from 28/01/2019 to 28/01/2019

Europe - EMA - European Medicines Agency

23-1-2019


Committee for Medicinal Products for Veterinary Use (CVMP): 22-24 January 2019 , European Medicines Agency, London, UK, from 22/01/2019 to 24/01/2019

Committee for Medicinal Products for Veterinary Use (CVMP): 22-24 January 2019 , European Medicines Agency, London, UK, from 22/01/2019 to 24/01/2019

Committee for Medicinal Products for Veterinary Use (CVMP): 22-24 January 2019 , European Medicines Agency, London, UK, from 22/01/2019 to 24/01/2019

Europe - EMA - European Medicines Agency

15-1-2019


Committee for Advanced Therapies (CAT): 7-9 November 2018, European Medicines Agency, London, UK, from 07/11/2018 to 08/11/2018

Committee for Advanced Therapies (CAT): 7-9 November 2018, European Medicines Agency, London, UK, from 07/11/2018 to 08/11/2018

Committee for Advanced Therapies (CAT): 7-9 November 2018, European Medicines Agency, London, UK, from 07/11/2018 to 08/11/2018

Europe - EMA - European Medicines Agency

10-1-2019


Stakeholder workshop on support to quality development in early access approaches, such as PRIME and Breakthrough Therapies, European Medicines Agency, London, UK, from 26/11/2018 to 26/11/2018

Stakeholder workshop on support to quality development in early access approaches, such as PRIME and Breakthrough Therapies, European Medicines Agency, London, UK, from 26/11/2018 to 26/11/2018

Stakeholder workshop on support to quality development in early access approaches, such as PRIME and Breakthrough Therapies, European Medicines Agency, London, UK, from 26/11/2018 to 26/11/2018

Europe - EMA - European Medicines Agency

7-1-2019


EU Innovation Network workshop with academia, European Medicines Agency, London, UK, from 16/11/2018 to 16/11/2018

EU Innovation Network workshop with academia, European Medicines Agency, London, UK, from 16/11/2018 to 16/11/2018

EU Innovation Network workshop with academia, European Medicines Agency, London, UK, from 16/11/2018 to 16/11/2018

Europe - EMA - European Medicines Agency

14-12-2018


Management Board meeting: 12-13 December 2018, European Medicines Agency, London, UK, from 12/12/2018 to 13/12/2018

Management Board meeting: 12-13 December 2018, European Medicines Agency, London, UK, from 12/12/2018 to 13/12/2018

Management Board meeting: 12-13 December 2018, European Medicines Agency, London, UK, from 12/12/2018 to 13/12/2018

Europe - EMA - European Medicines Agency

14-12-2018


European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, from 03/12/2018 to 03/12/2018

European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, from 03/12/2018 to 03/12/2018

European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, from 03/12/2018 to 03/12/2018

Europe - EMA - European Medicines Agency

11-12-2018


The new EudraVigilance system and the electronic reporting of individual case safety reports in the ISO/ICH E2B(R3) format: Hands-on training course, London, United Kingdom, from 11/02/2019 to 20/02/2019

The new EudraVigilance system and the electronic reporting of individual case safety reports in the ISO/ICH E2B(R3) format: Hands-on training course, London, United Kingdom, from 11/02/2019 to 20/02/2019

The new EudraVigilance system and the electronic reporting of individual case safety reports in the ISO/ICH E2B(R3) format: Hands-on training course, London, United Kingdom, from 11/02/2019 to 20/02/2019

Europe - EMA - European Medicines Agency

6-12-2018


Committee for Orphan Medicinal Products (COMP): 11-13 September 2018, European Medicines Agency, London, UK, from 11/09/2018 to 13/09/2018

Committee for Orphan Medicinal Products (COMP): 11-13 September 2018, European Medicines Agency, London, UK, from 11/09/2018 to 13/09/2018

Committee for Orphan Medicinal Products (COMP): 11-13 September 2018, European Medicines Agency, London, UK, from 11/09/2018 to 13/09/2018

Europe - EMA - European Medicines Agency

4-12-2018


16th Joint European Medicines Agency/European network for Health Technology Assessment dialogue meeting, European Medicines Agency, London, UK, from 07/12/2018 to 07/12/2018

16th Joint European Medicines Agency/European network for Health Technology Assessment dialogue meeting, European Medicines Agency, London, UK, from 07/12/2018 to 07/12/2018

16th Joint European Medicines Agency/European network for Health Technology Assessment dialogue meeting, European Medicines Agency, London, UK, from 07/12/2018 to 07/12/2018

Europe - EMA - European Medicines Agency

4-12-2018


Committee for Medicinal Products for Veterinary Use (CVMP): 4-6 December 2018, European Medicines Agency, London, UK, from 04/12/2018 to 06/12/2018

Committee for Medicinal Products for Veterinary Use (CVMP): 4-6 December 2018, European Medicines Agency, London, UK, from 04/12/2018 to 06/12/2018

Committee for Medicinal Products for Veterinary Use (CVMP): 4-6 December 2018, European Medicines Agency, London, UK, from 04/12/2018 to 06/12/2018

Europe - EMA - European Medicines Agency

29-11-2018


Multi-stakeholder workshop to launch consultation on European Medicines Agency (EMA) veterinary regulatory science to 2025, European Medicines Agency, London, UK, from 06/12/2018 to 06/12/2018

Multi-stakeholder workshop to launch consultation on European Medicines Agency (EMA) veterinary regulatory science to 2025, European Medicines Agency, London, UK, from 06/12/2018 to 06/12/2018

Multi-stakeholder workshop to launch consultation on European Medicines Agency (EMA) veterinary regulatory science to 2025, European Medicines Agency, London, UK, from 06/12/2018 to 06/12/2018

Europe - EMA - European Medicines Agency

29-11-2018


Committee for Medicinal Products for Human Use (CHMP): 15-18 October 2018, European Medicines Agency, London, UK, from 15/10/2018 to 18/10/2018

Committee for Medicinal Products for Human Use (CHMP): 15-18 October 2018, European Medicines Agency, London, UK, from 15/10/2018 to 18/10/2018

Committee for Medicinal Products for Human Use (CHMP): 15-18 October 2018, European Medicines Agency, London, UK, from 15/10/2018 to 18/10/2018

Europe - EMA - European Medicines Agency

28-11-2018


European Medicines Agency EudraVigilance and signal management information day, Hilton Canary Wharf, London, UK, from 07/12/2018 to 07/12/2018

European Medicines Agency EudraVigilance and signal management information day, Hilton Canary Wharf, London, UK, from 07/12/2018 to 07/12/2018

European Medicines Agency EudraVigilance and signal management information day, Hilton Canary Wharf, London, UK, from 07/12/2018 to 07/12/2018

Europe - EMA - European Medicines Agency

22-11-2018


Fourth industry stakeholder platform on research and development support, European Medicines Agency, London, UK, from 23/11/2018 to 23/11/2018

Fourth industry stakeholder platform on research and development support, European Medicines Agency, London, UK, from 23/11/2018 to 23/11/2018

Fourth industry stakeholder platform on research and development support, European Medicines Agency, London, UK, from 23/11/2018 to 23/11/2018

Europe - EMA - European Medicines Agency

22-11-2018


Paediatric Committee (PDCO): 16-19 October 2018, European Medicines Agency, London, UK, from 16/10/2018 to 19/10/2018

Paediatric Committee (PDCO): 16-19 October 2018, European Medicines Agency, London, UK, from 16/10/2018 to 19/10/2018

Paediatric Committee (PDCO): 16-19 October 2018, European Medicines Agency, London, UK, from 16/10/2018 to 19/10/2018

Europe - EMA - European Medicines Agency

21-11-2018


European Medicines Agency (EMA) / Heads of Medicines Agencies (HMA) / European Commission (EC) workshop on electronic product information (ePI), European Medicines Agency, London, UK, from 28/11/2018 to 28/11/2018

European Medicines Agency (EMA) / Heads of Medicines Agencies (HMA) / European Commission (EC) workshop on electronic product information (ePI), European Medicines Agency, London, UK, from 28/11/2018 to 28/11/2018

European Medicines Agency (EMA) / Heads of Medicines Agencies (HMA) / European Commission (EC) workshop on electronic product information (ePI), European Medicines Agency, London, UK, from 28/11/2018 to 28/11/2018

Europe - EMA - European Medicines Agency

18-7-2018

London Drugs Limited recalls Apex Premium LED Lighting Set

London Drugs Limited recalls Apex Premium LED Lighting Set

The battery box of the affected product may melt when the lights are turned on, posing fire and burn hazards.

Health Canada

10-9-2015

Christian Schneider appointed new NIBSC director

Christian Schneider appointed new NIBSC director

Christian Schneider, Medical Head of Division, has been appointed new director of the National Institute for Biological Standards and Control (NIBSC), which is located north of London, England.

Danish Medicines Agency

1-3-2019


EMA in London (1995-2019)

EMA in London (1995-2019)

EMA in London (1995-2019)

Europe - EMA - European Medicines Agency

9-1-2019

Omidria (Omeros London Limited)

Omidria (Omeros London Limited)

Omidria (Active substance: phenylephrine / ketorolac) - Centralised - Yearly update - Commission Decision (2019)68 of Wed, 09 Jan 2019

Europe -DG Health and Food Safety

22-11-2018

Vabomere (Rempex London Limited)

Vabomere (Rempex London Limited)

Vabomere (Active substance: meropenem/vaborbactam) - Centralised - Authorisation - Commission Decision (2018)7888 of Thu, 22 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4669/00

Europe -DG Health and Food Safety

19-9-2018

 12th Pharmacovigilance stakeholder forum, European Medicines Agency, London, UK, From: 24-Sep-2018, To: 24-Sep-2018

12th Pharmacovigilance stakeholder forum, European Medicines Agency, London, UK, From: 24-Sep-2018, To: 24-Sep-2018

This forum brings together regulators with patients, healthcare professionals and industry, to take stock of what we have achieved and what needs to be the focus over the coming years.

Europe - EMA - European Medicines Agency

18-9-2018

 Third industry stakeholder platform on research and development support, European Medicines Agency, London, UK, From: 18-May-2018, To: 18-May-2018

Third industry stakeholder platform on research and development support, European Medicines Agency, London, UK, From: 18-May-2018, To: 18-May-2018

This third meeting between regulators and representatives of industry stakeholder organisations addresses all areas of product-development support, including scientific advice, specifics for paediatric and orphan medicines and support for innovation. The meeting focuses on the implementation of the orphan notice, ‘histology-independent indications’ in the context of orphan designations, the upcoming rollout of a new tool for orphan designation applications, digital technology proposals in medicine develo...

Europe - EMA - European Medicines Agency

17-9-2018

 European Medicines Agency (EMA) Human Scientific Committees' Working Party with Healthcare Professionals’ Organisations (HCPWP), European Medicines Agency, London, UK, From: 26-Sep-2018, To: 26-Sep-2018

European Medicines Agency (EMA) Human Scientific Committees' Working Party with Healthcare Professionals’ Organisations (HCPWP), European Medicines Agency, London, UK, From: 26-Sep-2018, To: 26-Sep-2018

This Healthcare Professionals' Working Party (HCPWP) plenary meeting will include discussions on advances in clinical practice and the scientific and regulatory challenges. Members will also be invited to present how they are including regulatory sciences in fellowships and young researchers’ training. Feedback will be given from the representatives of the Scientific Committees.

Europe - EMA - European Medicines Agency

17-9-2018

 European Medicines Agency (EMA) Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and with Healthcare Professionals’ Organisations (HCPWP), European Medicines Agency, London, UK, From: 25-Sep-2018, To: 25-Sep

European Medicines Agency (EMA) Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and with Healthcare Professionals’ Organisations (HCPWP), European Medicines Agency, London, UK, From: 25-Sep-2018, To: 25-Sep

This joint Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Party (HCPWP) meeting will include results of the 2017 EMA perception survey. EMA regulatory science to 2025 will be discussed together with updates on Good Pharmacovigilance Practices (GVP). The Topic Group on Digital media and health will feedback to the working parties’ members. Participants will also receive an update on ongoing work on electronic product information and on availability of authorised med...

Europe - EMA - European Medicines Agency

17-9-2018

 European Medicines Agency (EMA) Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP), European Medicines Agency, London, UK, From: 25-Sep-2018, To: 25-Sep-2018

European Medicines Agency (EMA) Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP), European Medicines Agency, London, UK, From: 25-Sep-2018, To: 25-Sep-2018

This Patients' and Consumers' Working Party (PCWP) plenary meeting will include discussions on patient engagement along the regulatory lifecycle and visibility of patient input throughout scientific procedures. Feedback will also be given from the representatives of the Scientific Committees.

Europe - EMA - European Medicines Agency

13-9-2018

 European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, From: 03-Dec-2018, To: 03-Dec-2018

European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, From: 03-Dec-2018, To: 03-Dec-2018

This workshop on the development of medicines for chronic non-infectious liver diseases, including primary biliary cholangitis, primary sclerosing cholangitis and nonalcoholic steatohepatitis, provides a platform for discussion on appropriate endpoints including validation of surrogate endpoints/biomarkers, suitable study populations, potentially adequate trial designs and the specific challenges with paediatric medicine development. The workshop will support the drafting of a reflection paper on regul...

Europe - EMA - European Medicines Agency

12-9-2018

 Risk management plan information day, European Medicines Agency, London, UK, From: 25-Oct-2018, To: 25-Oct-2018

Risk management plan information day, European Medicines Agency, London, UK, From: 25-Oct-2018, To: 25-Oct-2018

This information day will update participants on the Agency’s medicine risk management activities and provide advice to marketing authorisation holders and applicants on drafting a risk management plan (RMP) in view of the full implementation of the second revision of the RMP template after the transitional period has elapsed. It will also provide an opportunity for an exchange of experiences with this template between regulators and industry. A dedicated session will discuss the streamlining of safety s...

Europe - EMA - European Medicines Agency

12-9-2018

 Committee for Medicinal Products for Veterinary Use (CVMP): 11-13 September 2018, European Medicines Agency, London, UK, From: 11-Sep-2018, To: 13-Sep-2018

Committee for Medicinal Products for Veterinary Use (CVMP): 11-13 September 2018, European Medicines Agency, London, UK, From: 11-Sep-2018, To: 13-Sep-2018

The Committee for Medicinal Products for Veterinary Use (CVMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning veterinary medicines.

Europe - EMA - European Medicines Agency

11-9-2018

 Risk assessment guideline focus group meeting, European Medicines Agency, London, UK, From: 19-Sep-2018, To: 19-Sep-2018

Risk assessment guideline focus group meeting, European Medicines Agency, London, UK, From: 19-Sep-2018, To: 19-Sep-2018

The Antimicrobials Working Party of the European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) is holding a focus group meeting with stakeholders to discuss the revision of the antimicrobial veterinary medicinal product risk assessment guideline, following a public consultation on the draft revised guideline ending on 31 October 2018. The meeting will focus on topics identified during this public consultation. This guideline aims to provide guidance to marketing authorisat...

Europe - EMA - European Medicines Agency

11-9-2018

 Focus group meeting  on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics harmonisation, European Medicines Agency, London, UK, From: 12-Oct-2018, To: 12-Oct-2018

Focus group meeting on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics harmonisation, European Medicines Agency, London, UK, From: 12-Oct-2018, To: 12-Oct-2018

This meeting will allow a direct exchange of views between the Agency’s working party and stakeholders on its draft reflection paper on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics (SPC) harmonisation (EMA/CVMP/849775/2017). It complements the public consultation on this reflection paper ending on 31 January 2019. The reflection paper follows considerations in the report on a pilot project that aimed to develop and test non-experimental appr...

Europe - EMA - European Medicines Agency

7-9-2018

 European network of paediatric research at the European Medicines Agency (Enpr-EMA) Coordinating Group and networks meeting, European Medicines Agency, London, UK, From: 08-Jun-2018, To: 08-Jun-2018

European network of paediatric research at the European Medicines Agency (Enpr-EMA) Coordinating Group and networks meeting, European Medicines Agency, London, UK, From: 08-Jun-2018, To: 08-Jun-2018

The 2018 face-to-face meeting of Enpr-EMA networks and coordinating members takes place after the annual open workshop on 8 June. The networks meeting will focus on the outcome of the 2018 annual workshop of the 7 June and the action plan for 2018/2019.

Europe - EMA - European Medicines Agency

7-9-2018

 2018 Annual workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), European Medicines Agency, London, UK, From: 07-Jun-2018, To: 07-Jun-2018

2018 Annual workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), European Medicines Agency, London, UK, From: 07-Jun-2018, To: 07-Jun-2018

Enpr-EMA will hold its tenth annual workshop on 7-8 June 2018 at EMA. The workshop brings relevant stakeholders together to discuss requirements, barriers and opportunities for the conduct of high-quality clinical studies in children. The overall theme of this year’s workshop will be a ‘holistic approach to paediatric research’. Highlights of this year’s workshop include: i) short perspectives of the various stakeholders involved in paediatric research (patient/young people advisory groups, research netw...

Europe - EMA - European Medicines Agency

28-8-2018

EU/3/18/2067 (Omeros London Limited)

EU/3/18/2067 (Omeros London Limited)

EU/3/18/2067 (Active substance: Recombinant human monoclonal antibody against mannan-binding lectin-associated serine protease-2) - Orphan designation - Commission Decision (2018)5737 of Tue, 28 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/044/18

Europe -DG Health and Food Safety

15-8-2018

Orbactiv (Rempex London Ltd)

Orbactiv (Rempex London Ltd)

Orbactiv (Active substance: oritavancin) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5556 of Wed, 15 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3785/T/20

Europe -DG Health and Food Safety

13-6-2018

Agenda:  Agenda and registration form - eXtended EudraVigilance medicinal product dictionary face-to-face training course, London, November 2018

Agenda: Agenda and registration form - eXtended EudraVigilance medicinal product dictionary face-to-face training course, London, November 2018

The training focuses on explaining the guidance and specifically the mandatory data elements necessary for the electronic submission of information on medicinal products, applying the format of the eXtended EudraVigilance Product Report Message (XEVPRM) and the use of the XEVMPD data entry tool (EVWEB). It includes exercises in the XEVPRM data entry tool (EVWEB) for the electronic submission and maintenance of different types of medicinal products.

Europe - EMA - European Medicines Agency

13-6-2018

Agenda:  Agenda and registration form - eXtended EudraVigilance medicinal product dictionary face-to-face training course, London, September 2018

Agenda: Agenda and registration form - eXtended EudraVigilance medicinal product dictionary face-to-face training course, London, September 2018

The training focuses on explaining the guidance and specifically the mandatory data elements necessary for the electronic submission of information on medicinal products, applying the format of the eXtended EudraVigilance Product Report Message (XEVPRM) and the use of the XEVMPD data entry tool (EVWEB). It includes exercises in the XEVPRM data entry tool (EVWEB) for the electronic submission and maintenance of different types of medicinal products.

Europe - EMA - European Medicines Agency